Published Papers & Misc - OKIYAMA Naoko

61. Tanboon J, Inoue M, Saito Y, Tachimori H, Hayashi S, Noguchi S, Okiyama N, Fujimoto M, Nishino I. Dermatomyositis: Muscle Pathology According to Antibody Subtypes. Neurology. 2022.02; 98 (7): e739-e749. ( PubMed, DOI )

62. Miyahara Hanako, Okiyama Naoko, Okune Mari, Konishi Risa, Miyamoto Masahide, Hara Monami, Iwabuchi Atsushi, Takada Hidetoshi, Nishino Ichizo, Nomura Toshifumi. Case of anti-nuclear matrix protein 2 antibody-positive juvenile dermatomyositis preceded by linear cutaneous lupus erythematosus on the face(和訳中) The Journal of Dermatology. 2022.01; 49 (1): e18-e19. ( ichushi )

63. Konishi Risa, Tanaka Ryota, Inoue Sae, Ichimura Yuki, Nomura Toshifumi, Okiyama Naoko. Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial(和訳中) The Journal of Dermatology. 2022.01; 49 (1): 118-123. ( ichushi )

64. Miyahara H, Okiyama N, Okune M, Konishi R, Miyamoto M, Hara M, Iwabuchi A, Takada H, Nishino I, Nomura T. Case of anti-nuclear matrix protein 2 antibody-positive juvenile dermatomyositis preceded by linear cutaneous lupus erythematosus on the face. The Journal of dermatology. 2022.01; 49 (1): e18-e19. ( PubMed, DOI )

65. Imanaka Y, Nakagawa Y, Yamaoka T, Kotobuki Y, Hayashi M, Katayama I, Ichimura Y, Okiyama N, Fujimoto M. Refractory dermatomyositis which developed in a patient with silicone breast implants. Allergology international : official journal of the Japanese Society of Allergology. 2022.01; 71 (1): 158-160. ( PubMed, DOI )

66. Imanaka Yoko, Nakagawa Yukinobu, Yamaoka Toshifumi, Kotobuki Yorihisa, Hayashi Misa, Katayama Ichiro, Ichimura Yuki, Okiyama Naoko, Fujimoto Manabu. Refractory dermatomyositis which developed in a patient with silicone breast implants(和訳中) Allergology International. 2022.01; 71 (1): 158-160. ( ichushi )

67. Ishitsuka Y, Ogawa T, Nakamura Y, Kubota N, Fujisawa Y, Watanabe R, Okiyama N, Fujimoto M, Roop DR, Ishida-Yamamoto A. Loricrin and NRF2 Coordinate Cornification. JID innovations : skin science from molecules to population health. 2022.01; 2 (1): 100065. ( PubMed, DOI )

68. Konishi R, Tanaka R, Inoue S, Ichimura Y, Nomura T, Okiyama N. Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial. The Journal of dermatology. 2022.01; 49 (1): 118-123. ( PubMed, DOI )

69. Matsumura Yutaka, Watanabe Rei, Niijima Yasuko, Kawakita Haruka, Furuta Junichi, Nakamura Yoshiyuki, Ishitsuka Yosuke, Okiyama Naoko, Fujisawa Yasuhiro, Fujimoto Manabu. 薬剤性過敏症症候群におけるエフェクターB細胞の活性化の可能性(Possible activation of effector B cells during drug-induced hypersensitivity syndrome) Journal of Cutaneous Immunology and Allergy. 2021.12; 4 (6): 166-169. ( ichushi )

70. Okiyama N, Iwasaki R, Fukuzono M, Endo R, Inoue S, Ichimura Y, Sato K, Tajiri K, Ieda M, Nomura T. Successful treatment of pulmonary hypertension with immunosuppressive therapy in a case of anti-synthetase syndrome. The Journal of dermatology. 2021.11; 48 (11): e545-e546. ( PubMed, DOI )

71. Okiyama Naoko, Iwasaki Riko, Fukuzono Maki, Endo Rumiko, Inoue Sae, Ichimura Yuki, Sato Kimi, Tajiri Kazuko, Ieda Masaki, Nomura Toshifumi. 抗合成酵素症候群患者における免疫抑制療法による肺高血圧症の治療(Successful treatment of pulmonary hypertension with immunosuppressive therapy in a case of anti-synthetase syndrome) The Journal of Dermatology. 2021.11; 48 (11): e545-e546. ( ichushi )

72. Fukuzono M, Sasaki K, Ichimura Y, Inoue S, Iwasaki R, Imai H, Saito A, Kubota N, Tanaka R, Nakamura Y, Fujisawa Y, Fujimoto M, Nomura T, Okiyama N. A case of anti-PL-7 antibody-positive anti-synthetase syndrome with dermatomyositis-associated erythema induced sclerodermatous changes. Rheumatology (Oxford, England). 2021.10; 60 (10): e362-e364. ( PubMed, DOI )

73. Oya Kazumasa, Ishitsuka Yosuke, Nakamura Yoshiyuki, Watanabe Rei, Okiyama Naoko, Fujimoto Manabu, Fujisawa Yasuhiro. Erdheim-Chester病における丘疹結節性病変(Papulonodular lesions in Erdheim-Chester disease) The Journal of Dermatology. 2021.09; 48 (9): e445-e446. ( ichushi )

74. Kawakami T, Okiyama N, Kodera M, Seishima M, Yamaguchi Y. The relationship between anti-phosphatidylserine/prothrombin complex IgM antibodies and cutaneous ulcers in patients with cutaneous vasculitis. The Journal of dermatology. 2021.09; 48 (9): 1457-1458. ( PubMed, DOI )

75. Shiga M, Miyazaki J, Tanuma K, Nagumo Y, Yoshino T, Kandori S, Negoro H, Kojima T, Tanaka R, Okiyama N, Fujisawa Y, Watanabe M, Yamasaki S, Kiyohara H, Watanabe M, Sato TA, Tahara H, Nishiyama H, Yano I. The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8⁺ T cells. Cancer immunology, immunotherapy : CII. 2021.09; 70 (9): 2529-2543. ( PubMed, DOI )

76. Ogawa T, Ishitsuka Y, Nakamura Y, Watanabe R, Okiyama N, Fujisawa Y, Fujimoto M. PD-1 Regulates Passive Anaphylaxis: A Possible Role of the Mast Cell Intracellular Inhibitory Signal. Allergy, asthma & immunology research. 2021.09; 13 (5): 819-821. ( PubMed, DOI )

77. Oya K, Ishitsuka Y, Nakamura Y, Watanabe R, Okiyama N, Fujimoto M, Fujisawa Y. Papulonodular lesions in Erdheim-Chester disease. The Journal of dermatology. 2021.09; 48 (9): e445-e446. ( PubMed, DOI )

78. Nakamura Y, Ishitsuka Y, Sasaki K, Ishizuki S, Tanaka R, Okiyama N, Furuta J, Fujimoto M, Yamada T, Fujisawa Y. A prospective, phase II study on the safety and efficacy of negative pressure closure for the stabilization of split-thickness skin graft in large or muscle-exposing defects: The NPSG study. The Journal of dermatology. 2021.09; 48 (9): 1350-1356. ( PubMed, DOI )

79. Maeda A, Nakamura Y, Ishizuki S, Kubota N, Okiyama N, Endo R, Iwasaki R, Oya K, Fujisawa Y. Invasive Squamous Cell Carcinoma and Numerous Bowen Disease Lesions of the Hand and Foot With Infection of HPV-18 and HPV-45. The American Journal of dermatopathology. 2021.09; 43 (9): 676-678. ( PubMed, DOI )

80. Nakajima M, Matsuyama M, Kawaguchi M, Matsumura S, Kiwamoto T, Matsuno Y, Morishima Y, Yoshida K, Sherpa MT, Yazaki K, Tanaka R, Okiyama N, Muratani M, Ishii Y, Hizawa N. Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium. Scientific reports. 2021.09; 11 (1): 18008. ( PubMed, DOI )